Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe site revision in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study page now renders a 403 Forbidden error instead of the study details, effectively blocking access to the IPROC record. The visible content shows a standard 403 layout and message.SummaryDifference20%

- Check29 days agoChange DetectedAdds a 'Find contact information' navigation label and updates the page to revision v3.7.0. This replaces the previous 'Find Contact Information' label and v3.6.6 revision.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor system/template update rather than a substantive change to the study details.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5. This represents a new platform build release, typically reflecting maintenance or bug fixes rather than changes to study details.SummaryDifference0.0%

- Check79 days agoChange DetectedA Publications section and a Study Results entry were added, including a citation for the IPROC sub-studies results. The page shows a new revision tag (v3.6.4) dated 2026-07-20, updating the study record with recent results dissemination.SummaryDifference0.4%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.